A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Clinical trial NCT03895203 · COMPLETED
Trial details
- NCT number
- NCT03895203
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2021-08-17
- Enrollment
- 852
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.